Clinical trial
Randomized, Double-blind, Phase III Study of the Efficacy and Safety of Miconazole Oil, Active Versus Placebo in the Treatment of Otomycosis
NCT05660382 is registered in ClinicalTrials.gov with Hill Dermaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Phase III Study of the Efficacy and Safety of Miconazole Oil, Active Versus Placebo in the Treatment of Otomycosis
- Lead sponsor
- Hill Dermaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 2, 2023
- Completion date
- December 27, 2024
- Enrollment
- 112 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.